$CLRB News Article - Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting
https://marketwirenews.com/news-releases/cell...19027.html